CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Behalf of CareDx, Inc. Shareholders

NEW YORK, July 12, 2022

This lawsuit is on behalf of all persons or entities who purchased CareDx common stock between February 24, 2021, and May 5, 2022.
Lead Plaintiff Deadline: July 22, 2022
No obligation or cost to you.

Learn more about your recoverable losses in CDNA:
https://www.kleinstocklaw.com/pslra-1/caredx-inc-loss-submission-form?id=29693&from=4

CareDx, Inc. NEWS - CDNA NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that CareDx, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the Company's RemoTraC service for remote, home-based, blood-drawing; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company's testing services revenue reported throughout the class period artificially inflated; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in CareDx you have until July 22, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased CareDx securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.